W-18 (drug)
W-18 (drug)[edit | edit source]
W-18 is a synthetic opioid analgesic that was first synthesized in the 1980s by a team of researchers at the University of Alberta. It is part of a series of compounds known as the W-series, which were initially developed for their potential analgesic properties.
Chemical Properties[edit | edit source]
W-18 is chemically classified as a benzodiazepine derivative, although it does not exhibit the typical effects associated with benzodiazepines. The chemical structure of W-18 is characterized by a complex arrangement of atoms that contribute to its potent analgesic effects.
Pharmacology[edit | edit source]
W-18 acts on the opioid receptors in the brain, which are responsible for mediating the effects of natural and synthetic opioids. Despite its classification as an opioid, W-18 does not bind to the mu-opioid receptor in the same way as traditional opioids like morphine or fentanyl. This unique binding profile contributes to its high potency and potential for abuse.
Effects and Potency[edit | edit source]
W-18 is reported to be extremely potent, with estimates suggesting it is up to 10,000 times more potent than morphine. This high potency raises significant concerns regarding its potential for overdose and toxicity. Users may experience effects similar to other opioids, including analgesia, euphoria, and respiratory depression.
Legal Status[edit | edit source]
Due to its high potency and potential for abuse, W-18 has been classified as a controlled substance in many countries. In the United States, it is listed as a Schedule I substance under the Controlled Substances Act, indicating that it has a high potential for abuse and no accepted medical use.
Synthesis and Discovery[edit | edit source]
W-18 was first synthesized by a team led by Dr. Edward Knaus at the University of Alberta. The compound was part of a larger research effort to develop new analgesics with improved safety profiles. However, W-18 and its analogs were not pursued for clinical development due to their extreme potency and potential for harm.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
